Autosomal Recessive Spastic Paraplegia Type 20
Description
Autosomal recessive spastic paraplegia type 20 (SPG20) is a type of complex hereditary spastic paraplegia characterized by an onset in infancy of progressive spastic paraparesis associated with distal amyotrophy, psuedobulbar palsy, motor and cognitive delays, mild cerebellar signs (dysarthria, dysdiadochokinesia, mild intention tremor), short stature and subtle skeletal abnormalities (pes cavus, mild talipes equinovarus, kyphoscoliosis). SPG20 is due to mutations in the SPG20 gene (13q13.1), which encodes the protein spartin.
Clinical Features
Top most frequent phenotypes and symptoms related to Autosomal Recessive Spastic Paraplegia Type 20
- Intellectual disability
- Global developmental delay
- Short stature
- Generalized hypotonia
- Microcephaly
- Growth delay
- Hypertelorism
- Failure to thrive
- Muscle weakness
- Spasticity
And another 84 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Autosomal Recessive Spastic Paraplegia Type 20 Is also known as troyer syndrome, childhood-onset spastic paraparesis-distal muscle wasting syndrome, spastic paraparesis, childhood-onset, with distal muscle wasting, spg20, spastic paraplegia, autosomal recessive, troyer type.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Autosomal Recessive Spastic Paraplegia Type 20 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
HSP, Comprehensive Evaluation.
By Athena Diagnostics Inc (United States).
RTN2, SACS, SPG11, ATL1, SPAST, SPG7, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A , (...)
View the complete list with 4 more genes
Specificity
5 %
Genes
100 % |
HSP, Supplemental Sporadic Evaluation.
By Athena Diagnostics Inc (United States).
RTN2, SACS, SPG11, ATL1, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A, L1CAM, KIF1A , (...)
View the complete list with 2 more genes
Specificity
5 %
Genes
100 % |
HSP, Supplemental Recessive Evaluation.
By Athena Diagnostics Inc (United States).
SACS, PNPLA6, SPART, SPG21, FA2H, AP5Z1, CYP7B1, ALS2, KIF1A
Specificity
12 %
Genes
100 % |
HSP, Complete Recessive Evaluation.
By Athena Diagnostics Inc (United States).
SACS, SPG11, SPG7, PNPLA6, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, CYP7B1, ALS2, KIF1A
Specificity
9 %
Genes
100 % |
Hereditary Spastic Paraplegia Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RTN2, SACS, SLC16A2, SLC2A1, KDM5C, SPG11, ATL1, SPAST, SPG7, TFG, ACOX1, TREX1, UCHL1, VAMP1, ERLIN2, CAPN1, BSCL2, SAMHD1, PNPLA6, ERLIN1 , (...)
View the complete list with 59 more genes
Specificity
2 %
Genes
100 % |
Test for Spastic Paraplegia 20.
By Genome Diagnostics Laboratory University Medical Center Utrecht (Netherlands).
SPART
Specificity
100 %
Genes
100 % |
HSPAR panel.
By Genome Diagnostics Laboratory University Medical Center Utrecht (Netherlands).
SACS, SPG11, SPG7, CCT5, PNPLA6, GJC2, SPART, SPG21, ZFYVE26, CYP7B1
Specificity
10 %
Genes
100 % |
Amyotrophic Lateral Sclerosis.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
ATXN2, SOD1, TARDBP, UBQLN2, VAPB, VCP, VEGFA, FIG4, OPTN, SPART, CHMP2B, DCTN1, C9orf72, FUS, ALS2, SETX, ANG, NEFH, SIGMAR1, PFN1 , (...)
View the complete list with 1 more genes
Specificity
5 %
Genes
100 % |
You can get up to 49 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
MESH ORPHANET OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39; EIEE39 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC BLADDER EXSTROPHY MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5 PROSTATE CANCER